“…IMRT, which modulates radiation intensity in a given field often with nine or more fields, allows delivery of more conformal dose, facilitating coverage of the clinical target with reduction of dose to surrounding normal organs at risk, possibly resulting in fewer treatment breaks and decreased overall treatment time [ 53 , 68 ]. Various retrospective and small prospective series demonstrated reductions in gastrointestinal and skin toxicity with the use of IMRT relative to the MMC arm of RTOG 98-11, where patients were treated with 2-dimensional or 3-dimensional conformal radiotherapy (3DCRT, Figure 1 ) [ 79 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 ]. Several institutional series compared patients treated with 3DCRT and IMRT and also demonstrated improved dermatologic and gastrointestinal toxicities, with comparable disease-specific outcomes compared to the MMC arm of RTOG 98-11 [ 85 , 93 , 94 , 95 , 96 , 97 , 98 ].…”